Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

Recs

0
Player Avatar OklaBoston (< 20) Submitted: 1/3/2012 1:34:52 PM : Outperform Start Price: $3.39 CBLI Score: -60.75

Cheap and enjoying much insider buying the last few months.

Featured Broker Partners


Advertisement